Literature DB >> 21940948

Positive cross-talk between hypoxia inducible factor-1α and liver X receptor α induces formation of triglyceride-loaded foam cells.

Tae-Young Na1, Hyo-Jeong Lee, Hyeon-Jeong Oh, Seung Huh, In-Kyu Lee, Mi-Ock Lee.   

Abstract

OBJECTIVE: Atherosclerosis is a chronic and progressive inflammatory disease of the arteries that is characterized by subendothelial accumulation of lipid-rich macrophages, called foam cells. We sought to identify the molecular details of cross-talk between liver X receptor α (LXRα) and hypoxia-inducible factor 1α (HIF-1α) for the formation of triglyceride-rich foam cells under hypoxic conditions. METHODS AND
RESULTS: We first observed that expression of LXRα and its target lipogenic genes was time-dependently induced in human primary macrophages and RAW 264.7 cells under hypoxia. Similarly, TO901317, an activator of LXRα, enhanced the expression level and the transcriptional activity of HIF-1α. Second, we demonstrated that LXRα increased HIF-1α protein stability through a physical interaction between the ligand binding domain of LXRα and the oxygen-dependent degradation domain of HIF-1α. Third, we found that the activation of HIF-1α or LXRα synergistically induced triglyceride accumulation in macrophages. Finally, we showed that LXRα and HIF-1α were codistributed in the macrophages of atherosclerotic lesions of patients.
CONCLUSIONS: These results suggest that the positive feed-forward regulation of transcriptional activity and protein stability of LXRα and HIF-1α has an important impact in foam cell formation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21940948     DOI: 10.1161/ATVBAHA.111.235788

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  8 in total

1.  LXRα Regulates oxLDL-Induced Trained Immunity in Macrophages.

Authors:  Hannes M Findeisen; Vivienne C Voges; Laura C Braun; Jannik Sonnenberg; Dennis Schwarz; Helena Körner; Holger Reinecke; Yahya Sohrabi
Journal:  Int J Mol Sci       Date:  2022-05-31       Impact factor: 6.208

Review 2.  Hypoxia in murine atherosclerotic plaques and its adverse effects on macrophages.

Authors:  Saj Parathath; Yuan Yang; Stephanie Mick; Edward A Fisher
Journal:  Trends Cardiovasc Med       Date:  2013-02-01       Impact factor: 6.677

3.  The importance of GLUT3 for de novo lipogenesis in hypoxia-induced lipid loading of human macrophages.

Authors:  Lu Li; Bo Liu; Liliana Håversen; Emma Lu; Lisa U Magnusson; Marcus Ståhlman; Jan Borén; Göran Bergström; Malin C Levin; Lillemor Mattsson Hultén
Journal:  PLoS One       Date:  2012-08-02       Impact factor: 3.240

4.  BNIP3 induction by hypoxia stimulates FASN-dependent free fatty acid production enhancing therapeutic potential of umbilical cord blood-derived human mesenchymal stem cells.

Authors:  Hyun Jik Lee; Young Hyun Jung; Gee Euhn Choi; So Hee Ko; Sei-Jung Lee; Sang Hun Lee; Ho Jae Han
Journal:  Redox Biol       Date:  2017-07-04       Impact factor: 11.799

5.  22-S-Hydroxycholesterol protects against ethanol-induced liver injury by blocking the auto/paracrine activation of MCP-1 mediated by LXRα.

Authors:  Tae-Young Na; Young-Hyun Han; Na-Lee Ka; Han-Su Park; Yun Pyo Kang; Sung Won Kwon; Byung-Hoon Lee; Mi-Ock Lee
Journal:  J Pathol       Date:  2015-01-05       Impact factor: 7.996

6.  Modulation of LXR signaling altered the dynamic activity of human colon adenocarcinoma cancer stem cells in vitro.

Authors:  Hassan Dianat-Moghadam; Mostafa Khalili; Mohsen Keshavarz; Mehdi Azizi; Hamed Hamishehkar; Reza Rahbarghazi; Mohammad Nouri
Journal:  Cancer Cell Int       Date:  2021-02-10       Impact factor: 5.722

Review 7.  Cholesterol and HIF-1α: Dangerous Liaisons in Atherosclerosis.

Authors:  Charles Thomas; Damien Leleu; David Masson
Journal:  Front Immunol       Date:  2022-03-21       Impact factor: 7.561

8.  Integrated Analysis Highlights the Immunosuppressive Role of TREM2+ Macrophages in Hepatocellular Carcinoma.

Authors:  Lisha Zhou; Meiling Wang; Hanrui Guo; Jun Hou; Yingna Zhang; Man Li; Xiangwei Wu; Xueling Chen; Lianghai Wang
Journal:  Front Immunol       Date:  2022-03-14       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.